VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30

VitaNova Life Sciences Corp

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026

$4.50+0.50 (+12.50%)

Close on Oct 19, 2026

Market cap: $37.52M
P/E (TTM): –
Dividend yield: –

VitaNova Life Sciences Corp cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-04-30	FY 2025 2025-04-30	FY 2024 2024-04-30	FY 2023 2023-04-30	FY 2022 2022-04-30	FY 2021 2021-04-30	FY 2020 2020-04-30	FY 2019 2019-04-30	FY 2017 2017-01-25
Stock-Based Compensation	0.18	0.00	0.00	0	–	–	–	–	–
Deferred Income Taxes	-0.02	0	–	–	–	–	–	–	–
Change in Accounts Receivable	0.48	-1.27	0	–	–	–	–	–	–
Change in Inventory	-0.06	0.09	-0.13	0	–	–	–	0	–
Change in Accounts Payable	0.21	-0.01	0.01	0.01	–	–	–	–	–
Operating Cash Flow	0.81	0.19	-0.38	-0.02	0.00	-0.04	-0.05	-0.05	-0.01
Investing Cash Flow	–	–	–	–	–	0	0	0	0.00
Stock Issued	–	–	–	–	–	–	–	0	0.00
Financing Cash Flow	0	0.00	0.96	0.00	0.02	0.04	0.05	0.04	0.01
Net Change in Cash	–	–	–	–	–	0	0	0.00	–
Income Taxes Paid	0.24	0	0	0.00	0	0	0	0	0
Interest Paid	0	0	0	0	0	0	0	0	0

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin: 26.9%
Operating margin: -2.7%
Net margin: -3.5%
Return on equity, FY2026: -1.9%

Financial strength

Current ratio: 7.13
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 514.7%

Valuation

P/E ratio: –
Price to sales: 11.57
Price to book: 19.46
Dividend yield: –